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Objective. To evaluate a new treadmill test, determining pain threshold speed (PTS) for use in assessment and measuring
rehabilitation of patients with intermittent claudication.
Methods and design. Twenty-nine patients with claudication were evaluated, and the ankle-brachial index (ABI) was
assessed. PTS was determined with a treadmill protocol based on level walking, low starting speed, and progressive
increments at a predetermined distance up to the onset of pain. Repeatability and equivalence with a time-based protocol were
verified. PTS was compared to pain-free walking distance, 6-minute walking distance, and ABI.
Results. PTS was measured in all patients (3.6 ^ 1.1 km/h). Repeatability and equivalence between established tests were
demonstrated. PTS showed a significant correlation with pain-free walking distance (r ¼ 0.833; P ¼ 0.0001), with 6-minute
walking distance (r ¼ 0.724; P ¼ 0.005), and with ABI in the more ischemic limb (r ¼ 0.641; P ¼ 0.0001).
Conclusions. PTS is a reliable parameter that correlates well with other established measures. It is useful for determining
the degree of functional handicap and for designing and guiding rehabilitation protocols.
Key Words: Claudication; Peripheral vascular disease; Tests.
Introduction
Claudication is typical of second-stage peripheral
arterial occlusive disease (PAOD), which affects 6%
of the US population aged 55 and older.1 The proven
effectiveness of physical exercise in reducing this
functional handicap2 – 6 has opened the way for
developing efficacious tests and methods that can be
used in designing optimal rehabilitation programs.
Currently, assessment of arteriopathic patients is
performed using tests based on a predetermined time7
or on determination of the critical distance to pain,
known as ‘pain-free walking distance’. This parameter
is obtained either through single-stage or progressive
protocols on the treadmill.4 The progressive method
appears to be more appropriate for evaluating arterio-
pathic patients, since it implies a gradual increase in
metabolic demand.8
Our group proposed a patient evaluation test based
on small speed increments that would eventually
cause the onset of the typical cramping pain.9 Our aim
was to define the functional handicap by a precise
individual critical speed, called the pain threshold
speed (PTS), rather than by a less specific distance to
the onset of pain, attained by walking at a fixed speed.
Painful cramping occurs at a walking speed that
differs from patient to patient and seems to be related
primarily to the degree of occlusive pathology and the
functionality of the collateral circulation.
Unlike other available methods, PTS could repre-
sent more than a useful tool for measuring the
outcome of rehabilitation. It could allow for the
development of a new rehabilitation strategy, similar
to the way that the anaerobic threshold is used in
sports training. This parameter, detectable through
laboratory and field tests, correlates with the running
pace in endurance competitions and is used to
establish training limits for high-quality training
sessions.10 – 12 Likewise, detection of the muscular
anaerobic threshold13 or another readily detectable
parameter could have similar applications in tailoring
rehabilitative programs in PAOD.
This parameter would enable physicians to dis-
criminate between anaerobic and submaximal aerobic
training sessions. Therefore, the aims of the present
study were to verify the feasibility and reproducibility
of the incremental walking speed test on a treadmill
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and to compare the parameters obtained to those
yielded by the current validated outcome measures for
assessing claudication.
Methods
Subjects
Twenty-nine patients (17 males, 12 females) gave their
informed consent to participate in this study,
approved by the local ethical committee. All patients,
with second stage PAOD, had presented with claudi-
cation for at least six months. Admission to the study
depended on clinical and cardiological evaluation.
Abstinence from smoking was mandatory in all
patients. Ongoing patient therapy was not modified
(no patients were taking beta-blockers).
Under rest conditions, all patients underwent
duplex scanning examination (Technos, 3.5 and 7.5
MH probe, Esaote Biomedics, Genova, Italy) to
evaluate arterial blood flow in the lower limbs. The
abdominal aorta, the common and external iliac, the
common, superficial and deep femoral, the popliteal
and both the tibial arteries were evaluated. High
resolution B-Mode imaging, complemented by PW
Doppler analysis for detection of arterial obstruction,
as well as peak-flow velocity for definition of critical
stenosis were used according to published stan-
dards.14,15 In addition, ankle pressure was measured
in the posterior tibialis and the dorsalis pedis arteries
of both legs. The ankle-brachial index (ABI) was
calculated and legs (better or worse) evaluated
separately.6 The patient population is described in
Table 1.
Pain threshold speed: determination and validation
Determination of the pain threshold speed
Twenty-nine patients underwent the incremental
protocol. The tests were performed in a temperature-
controlled environment of about 20 8C, equipped for
medical emergencies. Functional evaluations were
conducted during all seasons, in the morning between
9 am and 1 pm.
The patients were asked to rest well prior to the test,
to take their usual prescribed drugs, and to abstain
from caffeine. A heart rate monitor (Polar Electro Oy,
Finland) was applied to each patient. The test
procedure was explained, and patients were asked to
report promptly both the preliminary symptoms (heat,
paraesthesias) and, especially, the onset of the cramp-
ing pain, including intensity and location. Patients
were required to familiarize themselves with the
motorized treadmill (HRG 757, Carnielli Fitness,
Vittorio Veneto, Italy) by walking a few minutes on it
at a low speed. Those patients who chose to grip the
handrail used it during all subsequent tests.
The protocol employed only level walking on the
treadmill throughout the test and was preceded by a
warm-up at a walking speed of 1.5 km/h lasting
1 min. After 1 min of recovery, the test began at a
speed of 1.5 km/h. The evaluating physician, silent
during the test, increased the treadmill speed pro-
gressively by increments of 0.1 km/h every 10 m. The
patient’s heart rate was recorded at the end of each
10 m fraction. As soon as the patient reported painful
symptoms, the physician recorded the corresponding
speed (PTS) and heart rate. The test ended when the
patient was unable to continue because of pain and
had, therefore, reached his or her so-called maximal
speed. This parameter and the corresponding heart
rate were also recorded. The protocol called for test
interruption in case of dizziness or chest pain, or if the
patient’s heart rate reached approximately 80% of the
maximal theoretical (age-based) value. The test was
also interrupted if the patient was unable to keep up
with the speed imposed by the treadmill for any
nonvascular reason (e.g., age, biomechanical difficul-
ties, joint pathology).
Test repeatability
In order to determine whether PTS was subject to
inter-test variation, nine patients (six males, three
females) with different degrees of functional handicap
underwent the incremental test above described and
performed a second test after one hour, with identical
protocol.
Equivalence between tests with distance-based and time-
based protocols
In order to determine whether PTS was subject to
Table 1. General characteristics of the patient population
Sex/number Age (yr) Weight (kg) BMI Risk factors (%) Major lesion location (%) ABI
F/12 67.8 ^ 9.6 67.8 ^ 9.6 25.6 ^ 4.3 Smoking 62 Aorto-iliac 10 Worse 0.64 ^ 0.13
M/17 66.0 ^ 10.9 78.1 ^ 9.9 27.1 ^ 2.8 Hypertension 48 Fem-pop 31 Better 0.84 ^ 0.20
Familiarity 50 Infra-pop 3
Diabetes 38 Multiple 56
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variations depending on the protocol, 16 patients (10
males, 6 females) performed the incremental test and,
after one hour, a second test with a modified protocol
based on speed increments after a fixed time
(0.5 km/6000) instead of a predetermined distance.
During second tests, for evaluating repeatability
and equivalence between different protocols, the
physician interrupted the patient immediately after
PTS was detected, without allowing the patient to
attain maximal speed. These determinations of repeat-
ability and equivalence between protocols were single-
blind. At the end of each first test, during the rest
period, no information about the results was given to
the patient. During the second test, the treadmill’s data
panel showing speed and distance walked was not
visible to the subject.
Relationships between pain threshold speed and validated
outcome measures
Relationship between pain threshold speed and pain-free
walking distance
One hour after completion of the new incremental test,
28 patients (17 males, 11 females) were evaluated with
a progressive test used for determining pain-free
walking distance.8 After a warm-up of 1 min at
1.5 km/h, the treadmill speed was set to 3.2 km/h
and maintained unchanged. Every 2 min the slope of
the treadmill was increased by 2%. Patients were
asked to report the moment of pain onset to determine
the pain-free walking distance and the moment of the
highest pain tolerance (maximal walking distance), at
which the test was ended. Heart rate values were
recorded after each two-minute fraction, at pain-free
walking distance, and at maximal walking distance.
Relationship between pain threshold speed and 6-minute
walking distance
One hour after the incremental test, 13 patients were
evaluated to determine the 6-minute walking distance.
This test was conducted indoors, at a constant
temperature of approximately 20 8C. Patients were
instructed to walk back and forth along a 20 m
corridor alone and at their own pace, with the aim of
covering as much ground as possible in 6 minutes. If
pain occurred, patients were allowed to rest and to
re-start when possible. The physician who supervised
the test counted the laps and did not make any
comments or encourage the patients. At the conclusion
of the testing period, the 6-minute walking distance
was calculated.
Relationship between PTS and ABI
For the entire study population of 29 patients, the
previously calculated ABI values for both limbs were
correlated with PTS values.
Statistical analysis
Descriptive data are given as mean ^ SD. Repeat-
ability of tests was statistically evaluated by Passing-
Bablok linear regression analysis (to verify a possible
deviation from identity line ðy ¼ xÞ of values from two
matching measurement methods) and Bland-Altman
analysis, a typical ‘difference method’ for assessing
agreement between two measurement methods.
To describe the relationship between PTS and other
validated outcome measures a linear regression
analysis was performed and the strength of the linear
association was estimated by calculating the Pearson
Product Moment coefficient of correlation ðrÞ:
A P-value of 0.05 or less was considered statistically
significant. Statistical analysis was performed by
Medical statistical package 7.3.0 (Medcalc Software)
Mariakerke, Belgium.
Results
Pain threshold speed: determination and validation
Determination of pain threshold speed
PTS was determined in all cases. Pain was consistently
reported in the region related to the location of
vascularization deficit of the more ischaemic limb.
The mean values of PTS and maximal speed
recorded in the 29 patients were 3.6 ^ 1.1 km/h
(range 1.7–5.5) and 4.4 ^ 1.2 km/h (range 2.3–6.5),
respectively. The corresponding heart rate values were
96 ^ 13 beats/min (range 74– 135) and 103 ^ 15
beats/min (range 74–140).
Verification of test repeatability
The mean values of PTS recorded in the nine repeated
tests were 2.6 ^ 1.0 km/h (range 1.7 – 5.2) and
2.7 ^ 1.0 km/h (1.9–5.2), respectively. The corre-
sponding heart rate values were 91 ^ 10 beats/min
(range 78–108) and 93 ^ 10 beats/min (range 79–110).
The scatter plot and the Bland-Altman plot are
shown in Fig. 1. All the measures are included within
the limits of agreement. The same is true for the heart
rate recorded at PTS (Fig. 2).
Verification of equivalence between tests with distance-based
and time-based protocols
The mean values of PTS recorded in the 16 patients by
means of the two different incremental protocols were
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3.3 ^ 1.1 km/h (range 1.6–5.5) and 3.3 ^ 1.1 km/h
(range 1.5–5.5), respectively. The corresponding heart
rate values were 96 ^ 11 beats/min (range 76–122)
and 95 ^ 11 beats/min (range 72–118). The corre-
sponding scatter plots and the Bland-Altman plots are
shown in Figs. 3 and 4. In both cases all the measures
are included within the limits of agreement.
Relationship between pain threshold speed and validated
outcome measures
Assessment of relationship between pain threshold speed
and pain-free walking distance
For the 28 patients tested, the average PTS value was
3.5 ^ 1.1 km/h (range 1.7–5.5), while the average
pain-free walking distance measured was 167^
143 m (range 24–406), Fig. 5, r ¼ 0:833; P , 0:0001:
The corresponding heart rate values at the onset of
pain were 96 ^ 13 beats/min (range 64–135) and
98 ^ 13 beats/min (range 66–131), respectively. The
correlation coefficient was r ¼ 0:948; P , 0:0001:
The values of maximal speed and maximal walking
distance were 4.4 ^ 1.2 km/h and 253 ^ 168 m,
respectively (r ¼ 0:866; P , 0:0001).
Assessment of relationship between pain threshold speed
and 6-minute walking distance
For the 13 patients tested the average PTS value was
3.2 ^ 1.0 km/h (range 2.1–5.2), while the average
6-minute walking distance was 243.5 ^ 107.7 m (range
150–545). The data were significantly correlated
(r ¼ 0:724; P ¼ 0:005) and are shown in Fig. 5.
Assessment of relationship between PTS and ABI
The ABI was recorded in all patients. Average ABI
values for worse limb (Table 1) and the corresponding
PTS values showed a moderate but significant
correlation (r ¼ 0:641; P , 0:0001). In contrast, a
Fig. 1. Comparison of the pain threshold speed values
derived from the incremental test (PTS1) and from a second
test performed after one hour maintaining the same protocol
(PTS2) in nine patients. Top: Passing-Bablok regression
analysis. Regression equation: y ¼ 0:0000 þ 1:0000; 95% CI
for slope, 0.9091–1.3333; 95% CI for intercept, 20.7333 to
0.3273; not significant deviation from linearity ðP . 0:10Þ:
Bottom: difference plot shows the difference between PTS1
and PTS2 plotted against the average of the two data values.
The middle line represents the mean difference between
PTS1 and PTS2; the upper and lower dashed lines
represent ^ 2SD from the mean. No bias was observed.
Fig. 2. Comparison of the heart rate values at pain threshold
speed recorded during the incremental test (HRPTS1) and
during a second test performed after one hour maintaining
the same protocol (HRPTS2) in nine patients. Top: Passing-
Bablok regression analysis. Regression equation: y ¼
4:3478 þ 0:9783; 95% CI for slope, 0.4444–1.1667; 95% CI
for intercept, 212.0000 to 52.1111; not significant deviation
from linearity ðP . 0:10Þ: Bottom: difference plot shows the
difference between HRPTS1 and HRPTS2 plotted against the
average of the two data values. The middle line represents
the mean difference between HRPTS1 and HRPTS2; the upper
and lower dashed lines represent ^ 2SD from the mean. No
bias was observed.
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lower but significant degree of correlation was found
for the values recorded in the controlateral limb.
Discussion
The novel finding of our study is the demonstration
that claudication can be evaluated by means of an
individual critical speed at the onset of pain, rather
than by distance covered at a predetermined speed. A
previous test based on this critical-speed concept was
developed by our group9 but was not compared with
validated methods. The previous protocol, performed
in a corridor, necessitated highly trained assistants for
test reproducibility. The proposed treadmill method is
more standardized and reproducible in any ambulat-
ory setting, even by inexperienced operators.
The new test offered a precise indication of the
functional handicap of each patient, as PTS was
always determined. The low initial walking speed
and very small speed increments make it possible to
synchronize the haemodynamic supply with the
metabolic requirements of the patient, thereby pre-
venting the early activation of anaerobic glycolysis.
Level walking avoids the difficulty posed by inclin-
ation of the treadmill. Such a gradual and incre-
mental approach, as reported by others,8 allows for
accurate determination of the functional handicap of
patients with compromised vascular function and
claudication.
In using this methodological approach, we have
verified that the handicap described is related to
peripheral blood in-flow. Subjects with lower periph-
eral in-flow complained of early onset of pain in the
incremental test. This relationship has not always been
verified,16 particularly in single-stage tests, but has
Fig. 3. Comparison of the pain threshold speed values
derived from the incremental test (PTSD) and from a second
test performed after one hour with a modified protocol based
on speed increments after a fixed time (PTST) in 16 patients.
Top: Passing-Bablok regression analysis. Regression
equation: y ¼ 0:0000 þ 1:0000; 95% CI for slope, 0.9130–
1.1000; 95% CI for intercept, 20.2900 to 0.2435; not
significant deviation from linearity ðP . 0:10Þ: Bottom:
difference plot shows the difference between PTSD and
PTST plotted against the average of the two data values. The
middle line represents the mean difference between PTSD
and PTST; the upper and lower dashed lines represent ^ 2SD
from the mean. No bias was observed.
Fig. 4. Comparison of the heart rate values at pain threshold
speed recorded during the incremental test (HRPTS-D) and
from a second test performed after one hour with a modified
protocol based on speed increments after a fixed time
(HRPTS-T) in sixteen patients. Top: Passing-Bablok regression
analysis. Regression equation: y ¼ 12:0455 þ 0:8636£; 95% CI
for slope, 0.7059–1.2500; 95% CI for intercept, 224.6250 to
26.4118; not significant deviation from linearity ðP . 0:10Þ:
Bottom: difference plot shows the difference between HRPTS-D
and HRPTS-T plotted against the average of the two data
values. The middle line represents the mean difference
between HRPTS-D and HRPTS-T; the upper and lower dashed
lines represent ^ 2SD from the mean. No bias was observed.
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been demonstrated through use of progressive tests.17
The moderate degree of correlation is probably related
to the multifactorial origin of PTS, including gender,
biomechanics, oxygen transport and extraction, and
individual pain threshold. For these reasons, the
combined study of PTS and ABI allows a more
accurate characterization of the subject for purposes
of designing a rehabilitation program.
The new test was also shown to be repeatable and
independent of protocol modifications. In patients
who underwent two tests over a short period of time,
the reported onset of claudication pain was repeatable.
In fact, it occurred at the same walking speed and the
same level of cardiovascular effort (as indicated by
heart rate), independent of the degree of pathology.
Thus, this test can be used both for assessing
claudication and for monitoring functional improve-
ments during rehabilitation (e.g., higher walking
speeds attained). PTS and corresponding heart rates,
when not modified by a specific pharmacological
therapy, can also be used for evaluating other exercise-
induced cardiovascular adaptations, such as reduced
heart rate at specific exercise intensities.
As regards the test protocol, we recognize that
validated incremental tests usually employ a time-
dependent protocol, in which work-load is increased
after a fixed time. In our new test protocol, speed is
increased at fixed distance intervals, with a progress-
ive reduction in the duration of each fraction. In order
to exclude the possibility that PTS could be influenced
by this type of protocol, the patients performed a
second test, with time-based increments. The two
protocols provided highly correlated results. There-
fore, PTS seems to be intensity-related, that is, linked
to the increasing difference between oxygen supply
and demand upon progressive exercise intensity. The
proposed distance-based protocol is characterized by
accurate PTS measurement (to 0.1 km/h), reduced
exercise intensity and, consequently, little fatigue and
low cardiovascular risk. It is particularly suited to
patients with low functional reserve or for the first
evaluation of patients in general. Alternatively, the
time-based protocol could be used to test subjects with
relatively high functional reserves in order to verify
their walking capabilities at higher intensities for more
prolonged periods.
We did not test for possible inter-observer vari-
ations: during retest, we ‘blinded’ the patient and not
the operator. PTS corresponds to the moment (and
related speed) at which the subjective painful sen-
sation occurs and is known only by patient, rather than
operator, reporting. In addition, the test does not
require interpretation or any specific experience on the
part of the evaluating physician. The operator’s role is
to increase the treadmill speed progressively and to
record the patient’s speed, heart rate, and verbal
indications, without any communication that might
influence performance or test outcome.
Results from this new test compare well with results
from other validated walking tests. PTS showed a
good correlation with the parameter derived from a
traditional incremental test, the pain-free walking
distance. Heart rate values recorded at pain onset
were also comparable, suggesting a similar energy
output in the two tests.
The traditional protocol selected for this compari-
son, based on gradual variations in treadmill slope
and relatively short exercise periods, is probably the
closest methodological approach, among the tests
currently in use, to our study protocol. The primary
difference remains the relatively high starting speed
(3.2 km/h), which approximates the average PTS
found in our study population, so that in some
patients this initial effort could be responsible for an
early local production of muscle lactate.
A significant correlation was also verified between
our study results and those of a time-based walking
test, the 6-minute walking distance. In only one
case was an interesting difference found, probably
Fig. 5. Relationships between pain threshold speed against
pain-free walking distance by a graded test in use (Top) and
against the 6-minute walking distance by the 6-minute
walking test (Bottom).
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resulting from a high tolerance to muscle lactate in this
patient, who also exhibited and unusual differential
between PTS and maximal speed.
The results obtained with various walking tests
demonstrate that PTS compares favourably with the
other parameters currently in use. Is another test for
evaluating claudication needed? In our opinion, the
new test proposed in this study offers additional
benefits for rehabilitation programmes. The new test
assesses functional deficit and can be used for
designing and guiding rehabilitation. A target inten-
sity level of exercise training in these patients could
represent a strategic device to optimize the intensity–
duration relationship. Although PTS does not corre-
spond to the anaerobic threshold of the muscle groups
with reduced blood flow, it is noninvasive, easy to
measure, and guides the selection of training speeds.
A walking speed just below PTS induces less hypoxia,
is sustainable for longer periods, and produces the
well-known positive effects of aerobic training on the
cardiovascular system.18,19
Brief and fatiguing high-intensity sessions could
increase patients’ tolerance to pain, also resulting in
longer walking distances measured in subsequent
tests. However, such training sessions generally fail to
induce aerobic modifications20 and, in our experience
are not well tolerated, especially when prescribed for
patients to do at home. In contrast, when given
walking sessions to perform at progressive intensities
below PTS, our patients were able to walk increasingly
greater distances without pain.
In conclusion, PTS is a repeatable parameter, not
protocol-related, and correlated with validated out-
come parameters currently in use. Its potential
advantage in designing, guiding and monitoring
individual home-based rehabilitation programs war-
rants should be considered seriously.
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